We use essential cookies to make our website work. We would also like to set analytics cookies that help us make improvements by
measuring how our visitor use the website. These will be set only if you accept them. For further details on the cookies we use read our
Cookie Policy
To accept all cookies choose the “Accept All” button, otherwise make your selection for analytics cookies by clicking on the “Settings” bottom
Our Company
Recreating a future for Parkinson'sWho We Are
NeuroDerm is an agile, entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions. By integrating the unique, complementary strengths and diverse capabilities of Pharma and MedTech under one roof, we create synergies and value in the space between existing drugs and innovative treatments and technologies.
We develop next-generation drug-device combination solutions for central nervous system disorders through proprietary drug formulations, state of the art delivery systems and digital health technologies, connecting them all into a comprehensive solution for the benefit of patients and healthcare.
NeuroDerm is an Israel-based, wholly owned subsidiary of Mitsubishi Tanabe Pharma Corporation which, in turn, has global presence in Japan, United States, and Europe.
17
countries having recruiting clinical sites
>80
patents granted in over 15 jurisdictions
60%
of our employees are female
Company Milestones
Founded as an incubator company
2003
Awarded $1M by the MJFF for liquid carbidopa
2009
First liquid levodopa\carbidopa
2010
Awarded $1M by the MJFF for ND0612
2013
IPO, $45 million
2014
Follow-on IPO, $86.25 million
2016
Completed ND0612-006 (Phase II)
2016
Became a Mitsubishi Tanabe Pharma Group company
2017
Completed 1st year of ND0612 safety study
2019
Became part of the MCHC group
2020Meet our team
Kengo Isshiki
MSc – CEOMr. Isshiki was appointed NeuroDerm’s CEO in December 2022, after serving as NeuroDerm’s Chief Administrative Officer since 2020.
Uri David
MSc, MBA – CTOMr. David joined NeuroDerm in October 2019, bringing with him 36 years of experience in device R&D and production scale-up.
Tami Yardeni
MA – EVP Clinical DevelopmentMs. Yardeni joined NeuroDerm in 2016 and served as COO until the MTPC acquisition; she was then nominated EVP Clinical Development. She has over 20 years of experience in the pharmaceutical industry.
Adrian Gilbert
PhD – VP Pharmaceutical DevelopmentMr. Gilbert joined NeuroDerm in 2018 to lead the Pharmaceutical Development function, bringing more than 26 years of experience in the pharmaceutical industry.
Anat Nahmany
MSc – VP Human ResourcesMs. Nahmany joined NeuroDerm in 2016. She has over 20 years of experience in organizational transformation, strategy, change management, global development and building leadership teams.
Karin Baer
BSc - VP QualityMs. Baer joined NeuroDerm in 2021 as VP Quality, bringing with her more than 30 years’ experience in senior Quality positions in the pharmaceutical industry.
Lilach Shmueli-Dayan
MBA – VP FinanceMs. Shmueli-Dayan joined Neuroderm in 2020 as VP Finance. She has more than 20 years of experience in establishing and leading global finance organizations and leading strategic and transformational initiatives.
Ofer Ekbali
MBA – VP OperationsMr. Ekbali joined NeuroDerm in 2020 with over 19 years of experience in various operational management positions in the pharmaceutical industry.
Ziva Mesika
BSc – VP Regulatory AffairsMs. Mesika has more than 25 years of R&D and regulatory experience in the pharmaceutical industry. Joined NeuroDerm in 2016.
Yasutoshi Kawakami
BBus – Chairman of the BoardMr. Kawakami has been serving as a member of the board of directors since April 2020. He has extensive experience in leadership roles in the field of international business, serving more than 30 years at Mitsubishi Tanabe Pharma Corporation.
Mikio Himizu
BScMr. Himizu has been serving as a member of the board of directors since October 2017. He has extensive experience in various R&D roles, serving more than 30 years at Mitsubishi Tanabe Pharma Corporation.
Hitoshi Izaki
MSc, PharmacistMr. Izaki has been serving as a member of the board of directors since May 2020. He has extensive experience in various R&D roles, serving more than 30 years at Mitsubishi Tanabe Pharma Corporation.
Kenji Taguchi
PhDDr. Taguchi has been serving as a member of the board of directors since April 2020. He has more than 26 years of experience in various roles in the pharmaceutical industry.
Our mission
We are driven to reduce disease burden and improve the quality of life of patients and their families, with innovative drug-device combination therapies & technologies.
It’s all about our people
Naoki Mori CMC Project leaderWorking at NeuroDerm gives me many opportunities to develop my skills as a member of this global team. I get to expand my way of thinking and learn about different cultures by interacting with other NeuroDerm employees who work in various countries around the world.
Shmulik Ben Eliyahu Director, Head of Preclinical DevelopmentNeuroDerm is all about the people. It’s a great place to come to every day, and the teamwork is great too
Liat Adar Head of Clinical Pharmacology & ND0612 Global CPLI enjoy coming every day to a place where I can put my mind towards developing new meaningful solutions, in a rewarding and professional environment, knowing the impact our work has on people’s lives all over the world.
Muli Ben Hamo Sr. Manager, Business Strategy & Product ManagementI started my career at NeuroDerm 6 years ago, and my learning curve is still climbing. Every new challenge is an opportunity to step out of my comfort zone and grow.
Dr. Simon Israeli-Korn Scientific and Medical Senior DirectorNeuroDerm for me is more than a workplace; it is a community of colleagues and friends with whom I share a vision of allowing people with Parkinson’s and other neurological conditions to regain control of their lives.
Hila Eitan Director, General Counsel & Chief Compliance OfficerI’m very fortunate to be working at such an innovative company whose game-changing solutions will touch many Parkinson’s disease patients worldwide.
Nitsan Mane Electronic Eng. ManagerI’m fortunate to work in NeuroDerm’s unusual innovative environment, that integrate science and medical technology, hi-tech and pharma.
Dr. Nelson Felix Lopes Medical DirectorI’m happy to be part of such a dedicated team, combining the very best of both Pharma and MedTech. What we do today will have a significant impact on the health and wellbeing of thousands of patients worldwide tomorrow. Together we make a difference.
Maya Man Procurement ManagerI am proud to be part of a company that aims to improve the lives of Parkinson's patients around the world and strives for further medical achievements.
Moshe Hans Director Quality-ComplianceNeuroDerm is a place where, through multidisciplinary collaboration, we all learn from each other and develop personally and professionally, all while having fun.
Dr. Laurence Salin Senior Medical DirectorI really like working for NeuroDerm, a very “energizing” company with a real team spirit, everybody motivated by a shared goal of improving the life of people with Parkinson’s disease
Eliana Lavy Formulations ManagerThe NeuroGive volunteering project is without a doubt my favorite activity at the company. I'm happy to have this opportunity to contribute to the community at my workplace.
Ryan Case Senior Director, Head of Clinical Medical AffairsThe innovative, nimble culture at NeuroDerm makes for an exciting and rewarding environment.
Osnat Ehrman Sr. Director, NA Operation and Global Patient EngagementNeuroDerm is a global company in which you always feel connected, even when working from the other side of the globe
Let's Stay in Touch
For general inquiries or to learn more about NeuroDerm, please complete the form below. For medical information or to report on your own health or experience, please consult your healthcare provider. Please click here for information about our clinical trials.